| Entry |
|
|---|
| Name |
Cimetidine hydrochloride (USP);
Cimetidine hydrochloride (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C10H16N6S. HCl
|
|---|
| Exact mass |
288.0924
|
|---|
| Mol weight |
288.8002
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG01481 Histamine receptor H2 antagonist
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
|
|---|
| Remark |
| Product (DG00017): | D00295<JP/US> D03503<US> |
|
|---|
| Efficacy |
Anti-ulcerative, H2 receptor antagonist |
|---|
| Disease |
Duodenal ulcer [DS: H01634] Gastric ulcer [DS: H01634] Gastroesophageal reflux disease [DS: H01602] Zollinger-Ellison syndrome [DS: H01522] |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
CYP inhibition: CYP2D6 [HSA: 1565], CYP3A4 [HSA: 1576]
|
|---|
| Structure map |
| map07227 | Histamine H2/H3 receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02BA H2-receptor antagonists
A02BA01 Cimetidine
D03503 Cimetidine hydrochloride (USP) <US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Histamine2 (H2) Receptor Antagonists
Cimetidine
D03503 Cimetidine hydrochloride (USP)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG01481 Histamine receptor H2 antagonist
DG00017 Cimetidine
D03503 Cimetidine hydrochloride
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG00017 Cimetidine
D03503 Cimetidine hydrochloride
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
DG00017 Cimetidine
D03503 Cimetidine hydrochloride
Drug classes [BR:br08332]
Gastrointestinal agent
DG01481 Histamine receptor H2 antagonist
D03503 Cimetidine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH2
D03503 Cimetidine hydrochloride (USP) <US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03503
Drug groups [BR:br08330]
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG01481 Histamine receptor H2 antagonist
DG00017 Cimetidine
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG00017 Cimetidine
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
DG00017 Cimetidine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 18
1 X Cl 35.4200 -16.7300
2 C1b C 27.3161 -14.5481
3 S2a S 28.5286 -13.8510
4 C1b C 29.7410 -14.5481
5 C1b C 30.9533 -13.8510
6 N1b N 32.1656 -14.5481
7 C2c C 33.3840 -13.8510
8 N2b N 33.3840 -12.4455
9 N1b N 34.5963 -14.5481
10 C3b C 34.5963 -11.7484
11 C1a C 35.8088 -13.8510
12 N3a N 35.8237 -11.0526
13 C8y C 26.1233 -13.8569
14 N5x N 26.1233 -12.4555
15 C8x C 24.7904 -12.0225
16 N4x N 23.9666 -13.1562
17 C8y C 24.7904 -14.2900
18 C1a C 24.3563 -15.6258
BOND 17
1 2 3 1
2 3 4 1
3 4 5 1
4 5 6 1
5 6 7 1
6 7 8 2
7 7 9 1
8 8 10 1
9 9 11 1
10 10 12 3
11 2 13 1
12 13 14 1
13 14 15 2
14 15 16 1
15 16 17 1
16 13 17 2
17 17 18 1
|
|---|
